Pharmaceutical approval update.

Related Articles

Pharmaceutical approval update.

P T. 2014 Sep;39(9):619-20, 626

Authors: Goldenberg MM

Abstract
Belinostat (Beleodaq) for peripheral T-cell lymphoma; C1-esterase inhibitor (Ruconest) for acute attacks in hereditary angioedema; and tedizolid phosphate (Sivextro) for acute bacterial skin and skin structure infections.

PMID: 25210412 [PubMed]